NOMAD Power Solutions, Inc.(NMAD)

Biotechnology · Boca Raton, FL

$4.23+0.21 (+5.35%)

Delayed quote: Oct 6, 2026, 12:31 PM EDT

EV/FCF Ratio: N/A

Basis: Current FMP quote-based enterprise value / four-quarter operating cash flow less absolute capital expenditures. Source: stored company filings and market data; unavailable inputs remain N/A.

The EV/FCF ratio is N/A as of 2026-10-06T16:38:21.458Z.

Stored calculation inputs

Calculation as of: 2026-10-06T16:38:21.458Z.

Quote observation: 2026-10-06T16:31:29.000Z. Amounts in USD. The price header may show a later quote.

Quote market capitalization: 52,278,606
Total debt · period ending 2026-06-30: 1,101
Cash · period ending 2026-06-30: 12,670
TTM free cash flow · period ending 2026-06-30: -5,360,553

FMP input reference: f372f39edc86e990c580289f142e0fc1828f45467bffd466be8591b91f734aee

Free Cash Flow|FCF Yield|P/FCF Ratio|EV/EBITDA|All Metrics

Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.

NMAD EV/FCF Ratio Metrics

EV/FCF RATIO

N/A

NMAD Competitors' EV/FCF Ratio

NMAD

NOMAD Power Solutions, Inc.

Current

Market Cap

$52.28M

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

DWTX

Dogwood Therapeutics, Inc.

vs NMAD

Market Cap

$52.46M

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

COCH

Envoy Medical, Inc.

vs NMAD

Market Cap

$51.72M

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ELOX

Eloxx Pharmaceuticals, Inc.

vs NMAD

Market Cap

$51.72M

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

BTMD

biote Corp.

vs NMAD

Market Cap

$51.61M

EV/FCF Ratio

8.59x

TTM Avg

5.77x

3Y Avg

8.01x

5Y Avg

6.98x

EXOZ

eXoZymes, Inc.

vs NMAD

Market Cap

$51.42M

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ALDX

Aldeyra The

vs NMAD

Market Cap

$53.98M

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

RANI

Rani Therapeutics Holdings, Inc.

vs NMAD

Market Cap

$51.08M

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

CLNN

Clene Inc.

vs NMAD

Market Cap

$51.05M

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

IMA

ImageneBio Inc

vs NMAD

Market Cap

$53.63M

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NAME	MARKET CAP	EV/FCF RATIO	TTM	3Y	5Y
NOMAD Power Solutions, Inc. (NMAD)	$52.28M	N/A	N/A	N/A	N/A
Dogwood Therapeutics, Inc. (DWTX)vs ›	$52.46M	N/A	N/A	N/A	N/A
Envoy Medical, Inc. (COCH)vs ›	$51.72M	N/A	N/A	N/A	N/A
Eloxx Pharmaceuticals, Inc. (ELOX)vs ›	$51.72M	N/A	N/A	N/A	N/A
biote Corp. (BTMD)vs ›	$51.61M	8.59x	5.77x	8.01x	6.98x
eXoZymes, Inc. (EXOZ)vs ›	$51.42M	N/A	N/A	N/A	N/A
Aldeyra The (ALDX)vs ›	$53.98M	N/A	N/A	N/A	N/A
Rani Therapeutics Holdings, Inc. (RANI)vs ›	$51.08M	N/A	N/A	N/A	N/A
Clene Inc. (CLNN)vs ›	$51.05M	N/A	N/A	N/A	N/A
ImageneBio Inc (IMA)vs ›	$53.63M	N/A	N/A	N/A	N/A

Cash Flow Valuation Comparison

EV/FCF

N/A

P/FCF

N/A

FCF Yield

N/A

Formula: EV/FCF = Enterprise Value / Free Cash Flow

EV/FCF vs P/FCF:

EV/FCF accounts for debt and cash through enterprise value
P/FCF only considers equity value
EV/FCF can be compared across companies with different debt levels
Both measure how the market values cash generation

EV/FCF Ratio Formula & Definition

EV/FCF = Enterprise Value / Free Cash Flow (TTM)

Enterprise value to free cash flow compares total company value to the cash the business generates after capital expenditures.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

EV/FCF Ratio: N/A

NMAD EV/FCF Ratio Metrics

NMAD Competitors' EV/FCF Ratio

Cash Flow Valuation Comparison

EV/FCF Ratio Formula & Definition

Related Metrics